Search News

Corporate Industry Technology Medical Updates

MoyoAssist Extra-VAD

Medical Updates
The FIRST transseptal cannulation treatment via MoyoAssist Extra-VAD 2022-08-24
Corporate
Dr. Polin Hsu, has been elected as one of the 40 under 40 business elites by Fortune China. 2022-06-22
Technology
Latest on China-made ECMO: Beijing Anzhen Hospital, magAssist partner on ECMO R&D project 2022-03-24
Technology
magAssist receives keen international attention at the 47th European Society for Artificial Organs Congress 2021-09-13
Corporate
magAssist's extracorporeal ventricular assist device (Extra-VAD) was presented in the 2021 Suzhou New District Science and Technology Innovation Exhibition 2021-07-12
Corporate
magAssist was elected as the "2022 Future of Healthcare 100" 2022-06-17

Tabs： pVAD, cardiogenic shock, external life support systems, ECMO devices, IABP, Bridge-to-recovery, cardiogenic shock treatment, MoyoAssist Extra-VAD, solid technology of artificial hearts, Awards,